SYGNATURE DISCOVERY
DEAD

Serial Number

79411026

Owner

Sygnature Discovery Limited

Filing Date

Sep 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SYGNATURE DISCOVERY Trademark

Serial Number: 79411026

SYGNATURE DISCOVERY is a trademark filed by Sygnature Discovery Limited on September 27, 2024. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Sygnature Discovery Limited (2 trademarks)

The Discovery Building Biocity,

Entity Type: 99

Trademark Details

Filing Date

September 27, 2024

Registration Date

Not Registered

Goods & Services

Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods.

Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products.

Filing History

IRREGULARITY ON NOTICE OF POSSIBLE OPPOSITION RECEIVED FROM IB
May 6, 2026 IROP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 27, 2026 OPNR
DEATH OF INTERNATIONAL REGISTRATION
Nov 30, 2025 DETH
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 6, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 6, 2025 ABN2
REFUSAL PROCESSED BY IB
May 9, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 29, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 28, 2024 REPR